机译:恶性肝脏肿瘤中的程序死亡-1免疫检查点和肿瘤微环境
Department of Surgery The Ohio State University Wexner Medical Center;
Department of Surgery University of Washington Medical Center;
Department of Surgery The Ohio State University Wexner Medical Center;
First Department of Pathology National and Kapodistrian University of Athens;
First Department of Pathology National and Kapodistrian University of Athens;
Department of Surgery The Ohio State University Wexner Medical Center;
First Department of Pathology National and Kapodistrian University of Athens;
Department of Surgery University of Chicago Medicine Transplant Institute;
Department of Surgery The Ohio State University Wexner Medical Center;
Hepatocellular carcinoma; Immunotherapy; Inhibitory checkpoint; Liver; Malignancy; Program cell death;
机译:恶性肝脏肿瘤中的程序死亡-1免疫检查点和肿瘤微环境
机译:恶性胸膜间皮瘤肿瘤免疫微环境和免疫检查点的预后和预测方面
机译:oa02.07恶性胸腔间皮瘤肿瘤微环境的表征及免疫检查点表达的研究
机译:ADCS中使用的微管 - 解聚剂诱导抗肿瘤免疫,并用免疫检查点阻断抗体进行协同
机译:免疫检查点B7X促进肿瘤微环境中调节性T细胞的诱导,并介导对免疫疗法的抗性
机译:通过分析细胞死亡-1(PD-1)靶向治疗前后分析肿瘤细胞 - 细胞通信的响应或抗免疫检查点抑制剂的机制:使用单细胞RNA和Buk-RNA测序数据的一致性分析
机译:通过分析细胞死亡-1(PD-1)靶向治疗前后分析肿瘤细胞 - 细胞通信的响应或抗免疫检查点抑制剂的机制:使用单细胞RNA和Buk-RNA测序数据的一致性分析
机译:启动肿瘤免疫微环境可改善癌症干细胞的免疫监视并预防癌症复发。